1. Home
  2. NYAX vs MLYS Comparison

NYAX vs MLYS Comparison

Compare NYAX & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nayax Ltd.

NYAX

Nayax Ltd.

N/A

Current Price

$60.85

Market Cap

2.3B

Sector

N/A

ML Signal

N/A

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$23.51

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYAX
MLYS
Founded
2005
2019
Country
Israel
United States
Employees
1200
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2022
2023

Fundamental Metrics

Financial Performance
Metric
NYAX
MLYS
Price
$60.85
$23.51
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$49.50
$48.67
AVG Volume (30 Days)
15.4K
1.1M
Earning Date
03-09-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$25.96
N/A
Revenue Next Year
$19.69
N/A
P/E Ratio
$89.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$32.38
$10.44
52 Week High
$61.50
$47.65

Technical Indicators

Market Signals
Indicator
NYAX
MLYS
Relative Strength Index (RSI) 62.08 30.24
Support Level $42.63 $13.42
Resistance Level $60.77 $31.09
Average True Range (ATR) 1.17 1.76
MACD 0.48 -0.30
Stochastic Oscillator 88.47 11.34

Price Performance

Historical Comparison
NYAX
MLYS

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It unifies payments, operations management, and customer engagement tools into a powerful, adaptable platform for modern commerce. It provides solutions that empower businesses to enhance customer experience, accept cashless payments, and manage their operations with a robust Internet of Things (IoT) software platform, helping achieve long-term growth. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: